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Abbreviations 
LDL – low-density lipoprotein 
ROS – reactive oxygen species 
PUFA – polyunsaturated fatty acid 
4-HNE – trans-4-hydroxy-2-nonenal 
RCT – randomized controlled trial 
TEAC – trolox equivalent antioxidant capacity 
DPPH – 2,2-diphenyl-1-picrylhydrazyl 
FRAP – ferric reducing antioxidant power 
ADME – absorption, distribution, metabolism and excretion 
PKC – protein kinase C 
PI3K – phosphoinositide-3-kinase 
TAK1 – TGF-beta-activated kinase 1 (mitogen-activated protein kinase kinase kinase 7) 
PDK1 – 3-phosphoinositide dependent protein kinase 1 
AKT – AKT serine/threonine kinase 
NF-κB – nuclear factor kappa B 
TNFα – tumor necrosis factor-alpha 
MEK2 – dual specificity mitogen-activated protein kinase kinase 2 
IKKα – NF-κB inhibitor kinase alpha 
ERK – mitogen-activated protein kinase 
eNOS – endothelial nitric oxide synthase 
AMPK – AMP-activated protein kinase 
miRNA – microRNA 
p38-MAPK – p38 mitogen-activated protein kinase 
HDL – high-density lipoprotein 
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Abstract 
Oxidative damage of cells and tissues is broadly implicated in human pathophysiology, including 
cardiometabolic diseases. Polyphenols, as important constituents of human diet and potent in 
vitro free radical scavengers, have been extensively studied for their beneficial effects on 
cardiometabolic health. However, it has been demonstrated that the in vivo antioxidant activity of 
polyphenols is distinct from their in vitro free radical scavenging capacity. Indeed, 
bioavailability of nutritional polyphenols is low, and conditioned by complex mechanisms of 
absorption, distribution, metabolism and excretion. Nowadays it is commonly accepted that the 
cellular antioxidant activity of polyphenols is mainly carried out via modification of transcription 
of genes involved in antioxidant defense. Importantly, polyphenols contribute to the 
cardiometabolic health also by modulation of plethora of cellular processes that are not directly 
associated with antioxidant enzymes, through nutri(epi)genomic mechanisms. Numerous human 
intervention studies have demonstrated beneficial effects of polyphenols on the key 
cardiometabolic risk factors. However, inconsistency of the results of some studies led to 
identification of the inter-individual variability in response to consumption of polyphenols. In 
perspective, a detailed investigation of the determinants of this inter-individual variability will 
potentially lead us towards personalized dietary recommendations. The phenomenon of inter-
individual variability is also of relevance for supplementation with antioxidant (pro)vitamins. 
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Introduction 
Nutrition is essential for maintenance of optimal health. Both under- and overnutrition lead to 
disease development and increase in the rate of mortality. Both phenomena are still present in the 
human society, and it is rather difficult to overcome them, despite the unprecedented 
technological advances in food science the past few decades. In addition, we witness occurrence 
of obesity accompanied by deficit of essential nutrients and plant food bioactives in low- and 
middle-income countries, as well as in low-income subgroups in developed countries(1,2). Other 
than economic status, it has also been suggested that the educational status has a significant 
influence on food choices(3). 
Plant food bioactives are important constituents of human diet. Although not classified as 
essential nutrients, they may have beneficial effects on human health. Unlike vitamins, their 
inadequate intake will not result in specific syndrome of deficit, but rather in increased risk of 
chronic diseases. The plant food bioactives include terpenoids (isoprenoids), phenolic 
compounds (including polyphenols), glucosinolates, betalains and others. In this review, we will 
focus on polyphenols and their effects on human cardiometabolic health. Indeed, there is 
growing evidence about the preventive effects of polyphenols on cardiometabolic diseases, such 
as Diabetes mellitus type 2(4) and atherosclerosis(5). There is also evidence that polyphenols exert 
beneficial effects on neurodegenerative diseases(6) and some forms of cancer(7), which will not be 
addressed in this occasion. 
Because of their remarkable in vitro free radical scavenging properties, early investigators 
attributed the beneficial effects of polyphenols on human health exclusively to their capacity to 
scavenge free radicals(8,9). Regarding their cardioprotective effects, many studies were focused 
on LDL oxidation, which plays central role in atherogenesis(10). Indeed, it has been demonstrated 
that, upon consumption of foods and beverages rich in polyphenols, the resistance of LDL to 
oxidation increases(11). Notably, LDL oxidizability is still of interest(12). Following these 
observations, polyphenols became an integral part of the theory of oxidative stress. 
Therefore, in the first part of this review we will give an overview of the theory of oxidative 
stress and a summary of the results of antioxidant supplementation studies. In the second part, 
we will focus on polyphenols and their antioxidant properties, which will be followed by an 
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overview of their effects on cardiometabolic health, and our current understanding of the inter-
individual variability in the response of their consumption. 
1. Oxidative stress and antioxidant supplementation 
1.1 Definition of oxidative stress and mechanism of lipid peroxidation 
The term “free radical” refers to the chemical species containing one or more unpaired electrons, 
which encompass various oxygen-, carbon-, nitrogen- or sulfur-centered radicals. Among them, 
the oxygen-centered radicals are the most prevalent in the biological systems(13), including the 
superoxide radical, and the highly reactive hydroxyl radical. These, along with the non-radical 
hydrogen peroxide, are the most common reactive oxygen species (ROS). Following Harman’s 
free radical theory of aging (1956)(14), the term “oxidative stress” was first mentioned in 1970, 
referring to the oxidative challenge of erythrocytes by hydrogen peroxide(15). In 1985 oxidative 
stress was defined as an imbalance between oxidants and antioxidants, in favor of the former(16), 
focusing on the oxidative damage of cells, tissues and organs(17). Since then, the concept has 
evolved substantially, leading to redefinition of oxidative stress as a dysfunction of cellular redox 
signaling and redox control(18,19). Most recently, a distinction has been made between oxidative 
eustress, as a physiological condition that is essential for redox signaling, and oxidative distress, 
as a supraphysiological condition that causes damage to biomolecules(20). So far, hundreds of 
thousands of papers have been published demonstrating and confirming the association of 
oxidative stress with various human diseases, including cardiometabolic ones. Indeed, nowadays 
it is almost impossible to find a human disease or condition that is not associated with the 
oxidative stress. 
Classical theory describes the oxidative stress as an overall imbalance between the ROS from 
one side, and the cellular antioxidants from the other, of course in favor of ROS. This imbalance 
occurs because of an excessive production of ROS, or an inadequate concentration and/or 
activity of the cellular antioxidants (non-enzymatic or enzymatic), or because of both(21). The 
classical understanding of the oxidative stress was a leitmotif of the early attempts to translate 
the immense amount of scientific evidence into clinical practice. Within these efforts, it seems 
that the chain reaction of lipid peroxidation attracted most attention. Hydroxyl radical (HO.), as 
the most reactive ROS, reacts in a high rate reaction with polyunsaturated fatty acids (PUFAs), 
in the first place linoleic or arachidonic acid of membrane phospholipids. Hydroxyl radical 
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abstracts hydrogen atom from PUFA, which starts the autocatalytic chain reaction of lipid 
peroxidation. In this initiating reaction, a carbon-centered lipid radical is formed (L.), which 
further reacts with molecular oxygen to generate an oxygen-centered lipid peroxyl radical 
(LOO.). The lipid peroxyl radical can attack another PUFA to generate lipid hydroperoxide 
(LOOH) and a new carbon-centered lipid radical, which propagates the chain reaction(22). Lipid 
hydroperoxides have ability to react with trace metals to generate lipid alkoxyl radicals (LO.). 
Both lipid peroxyl radicals and lipid alkoxyl radicals undergo cyclization and/or degradation, 
generating a plethora of reactive aldehydes such as malondialdehyde (MDA), trans-4-hydroxy-2-
nonenal (4-HNE), trans-4-oxo-2-nonenal (4-ONE), acrolein, glyoxal and many others. What 
reactive aldehydes will be generated depends on the type of PUFA subjected to lipid 
peroxidation(23). Importantly, these reactive aldehydes have ability to oxidize proteins(24) and 
DNA(25). Therefore, if present in excess and/or for a longer period, they can induce cellular 
damage, and consequently induce disease development. 
Lipid peroxyl radicals can be scavenged by vitamin E, but also by other nutrients such as 
polyphenol, or beta-carotene(26), which terminates the chain reaction of lipid peroxidation. 
Notably, the chemistry behind the scavenging of lipid peroxyl radicals by polyphenols and 
vitamin E is very similar(27). Following the reaction of termination by the vitamin E, a relatively 
stable α-tocopheryl radical is formed (α-tocopherol is the predominant form of vitamin E in 
human tissues(28)). The α-tocopheryl radical can be oxidized to a stable nonradical quinone, or 
reduced back (recycled) to hydroqiuinone by vitamin C(29). However, the biological relevance of 
the later reaction is not completely clear(30). Other possibilities for termination of the chain 
reaction of lipid peroxidation are the following: substrate unavailability, collision of two LOO. 
molecules or reaction of LOO. with other radicals. 
1.2 Antioxidant supplementation studies – hopes and pitfalls 
Undoubtedly, if present at high concentrations, ROS, free radicals and reactive aldehydes will 
cause cellular damage, and eventually disease. Therefore, for early investigators, it seemed 
logical that supplementation with low molecular weight antioxidants would prevent the cellular 
damage, resulting in beneficial effects on human health, and decreased mortality. Following this 
assumption, numerous randomized controlled trials (RCTs) have been conducted with the aim to 
study the effects of supplementation with vitamin C, vitamin E, beta-carotene, vitamin A and 
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selenium, alone or in various combinations, on oxidative stress and health maintenance. Some of 
these studies included patients with various chronic diseases. In others, the relevance of 
antioxidant supplementation in primary prevention was studied on healthy subjects. A meta-
analysis of 67 RCTs was conducted and published in 2008(31), the results of which were 
discouraging. The same authors repeated the meta-analysis, including the papers that were 
published subsequently and the updated meta-analysis of 78 RCTs was published in 2012(32). The 
results were similar, i.e. showing “no evidence to support health effects of supplementation with 
low molecular weight antioxidants in both primary and secondary prevention”. Moreover, it has 
been demonstrated that supplementation with vitamin E, beta-carotene and vitamin A may 
slightly increase mortality. After the initial disappointment, a quest for rational explanation has 
been initiated, and several important issues have been raised, which will be presented in the 
following paragraphs. 
Over-simplification of the theory of oxidative stress has been identified as an important cause of 
the disappointing results of the antioxidant supplementation studies, which were an attempt to 
translate the accumulated scientific evidence into practice. This over-simplification has been 
referred as a “translational shortcut”(33). Indeed, behind the simplified representation of the 
oxidative stress as an overall imbalance between ROS and antioxidants, there is a complex 
network of cellular redox regulators. These include antioxidant enzymes and low molecular 
weight antioxidants that work together, and along with other cellular factors, to establish and 
maintain the cellular redox balance. Obviously, an over-simplification of this complex network 
down to unselective supplementation with high doses of free radical scavengers was not 
effective. Moreover, the finding of increased mortality points out that “natural”, which refers to 
both vitamin E and beta-carotene, is not equal to “safe in high doses”. Another potential issue 
might be the composition and/or quality of supplements, which would be extremely difficult to 
address from our perspective. 
In the antioxidant supplementation studies, an important factor that should have been taken into 
account is the role of reactive aldehydes as second messengers of free radicals. Indeed, there is 
evidence that, in its physiological concentrations, 4-HNE acts as a signaling molecule, and as 
such is involved in many biological processes(34), including adaptive response to other oxidative 
stressors(35). Therefore, supplementation with high doses of vitamin E may impair the 
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physiological role of 4-HNE, potentially leading to adverse effects. It is indicative that an 
increased mortality was observed in supplementation with vitamin E, beta-carotene, and vitamin 
A, all of them liposoluble compounds, but not with vitamin C. Indeed, liposolubility aggravates 
elimination, which may be an important element for development and manifestation of adverse 
effects. 
Vitamin E(36) and beta-carotene(37) have multiple biological functions. Currently, it is not 
completely understood how these functions were implicated in the results of the RCTs of 
antioxidant supplementation. However, some aspects have been discussed in a recent review(38). 
Namely, it has been demonstrated that beta-carotene inhibits the enzymatic activity of 
glutathione-S-transferase pi, which provides protection against BPDE (benzo[a]pyrene diol 
epoxide), a toxic metabolite of tobacco smoke. The decreased enzymatic activity of glutathione-
S-transferase pi has been proposed as underlying mechanism of the increased incidence of lung 
cancer in smokers supplemented with beta-carotene(39). On the other hand, it has been 
demonstrated that vitamin E supplementation has beneficial health effects in specific groups of 
patients(40), such as patients with non-alcoholic steatohepatitis(41), diabetic patients with 
haptoglobin 2-2 genotype(42), patients on hemodialysis(43), and patients with oxidative stress 
induced hypertension(44). Moreover, some meta-analyses did not confirm the finding regarding 
the increased mortality in persons supplemented with vitamin E(45,46). These examples illustrate 
the need to identify population groups and individuals that will most benefit from 
supplementation with antioxidant vitamins, as precisely as possible, including the dose and 
duration of supplementation. To the best of our knowledge, the inter-individual variability of 
response to low molecular weight antioxidants has not been explored in detail so far. Biomarkers 
of oxidative stress(47) shall be used for identification of patients that will most benefit of 
supplementation with antioxidant vitamins. However, the shortcomings of the currently available 
biomarkers(48) do not allow their effective use in clinic. Therefore, a development of better, 
biologically much more specific and analytically more precise biomarkers of oxidative stress, is 
of utmost importance. 
2. Polyphenols and their antioxidant properties 
2.1 Polyphenols in human diet 
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Polyphenols are plant food bioactives that possess remarkable in vitro antioxidant capacity(49). 
They have ability to scavenge lipid peroxyl radicals(50). As such, they are an integral part of the 
theory of oxidative stress(51). Polyphenols are present at relatively high concentrations in human 
diet. However, depending on individual(52) and national nutrition habits, there is a large 
difference in daily consumption, ranging from 377±15(53), to 1757±696(54) mg/day. Dietary 
polyphenols originate mainly from plant based foods including fruits (mainly berries and apples), 
vegetables (onions, spinach, asparagus, broccoli), spices (black pepper, curcuma, saffron), whole 
grains, coffee, cocoa, tea, olive and various kinds of nuts(55). Many of them are also administered 
as food supplements or herbal remedies. Polyphenols are well studied and classified. They are 
widespread in the plants, encompassing over 8000 different compounds(56). However, the number 
of polyphenols that are relevant to human nutrition is much smaller. Two databases containing 
comprehensive information on nutritional polyphenols have been developed and are freely 
accessible: (http://phenol-explorer.eu/)(57) and 
(https://www.ars.usda.gov/ARSUserFiles/80400525/Data/Flav/Flav_R03-1.pdf)(58). 
Regarding the health benefits of consumption of foods and beverages rich in polyphenols, the 
first epidemiological study demonstrating an inverse association between flavonoid intake and 
mortality from coronary heart disease was published in 1993(59). Unfortunately, another 
translational shortcut was taken here. Since polyphenols demonstrate high in vitro antioxidant 
capacity, it was assumed that the in vitro antioxidant capacity of any food or plant extract can be 
used as a direct determinant (or, in other words, a measure) of their beneficial health effects in 
humans. Following this concept, a list of in vitro antioxidant capacities of foods and beverages 
(measured with Oxygen Radical Absorbance Capacity assay – ORAC assay) was published(60). 
Besides the ORAC assay(61,62), several other methods were also developed, such as TEAC, DPPH 
and FRAP assay(63). However, growing scientific evidence started to elucidate some of the 
numerous and complex mechanisms of absorption, distribution, metabolism and excretion 
(ADME) of polyphenols, as molecular basis of their low bioavailability. It also became clear that 
the in vivo antioxidant activity of polyphenols involves much more complex mechanisms than 
the free radical scavenging, and that molecular mechanisms that are not directly associated with 
the antioxidant enzymes are also involved in their health promoting effects. At the same time, the 
ORAC list was misused by food and dietary supplement manufacturing companies to promote 
their products(64). All this together led to withdrawal of the ORAC list. 
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2.2 Metabolism of nutritional polyphenols in the human body 
Bioavailability of nutritional polyphenols is low, and far from uniform. Their plasma 
concentrations are at range of nM to low µM(65). A notable exception is the gastrointestinal 
tract(66), where the intestinal cells are in contact with high concentrations of polyphenols and 
other plant food bioactives. In the human body, polyphenols are subjected to complex and 
extensive metabolic transformations(67), which significantly alter their chemical properties, and 
sometimes diminish their antioxidant activity(68). Notably, lack of association between the 
antioxidant activity and some of the biological effects of polyphenol metabolites has been clearly 
observed(69). Therefore, the in vitro total antioxidant capacity of foods, beverages or plant 
extracts, cannot be a direct determinant of their biological effects. 
Polyphenols are a heterogeneous family of plant food bioactives, encompassing several classes 
of bioactive compounds, such as flavonoids, phenolic acids, lignans, stilbenes, and other 
polyphenols(57). Because of the heterogeneity in their chemical structures, the metabolism of 
compounds that belong to different classes and subclasses, or even the metabolism of individual 
compounds, is different, which has been extensively reviewed elsewhere(67,70). Here, we will give 
only a general overview of the metabolism of polyphenols, pinpointing the factors that are 
relevant for the inter-individual variability in the response to their consumption. In the human 
diet, most of the polyphenols are found as glycosides. Hydrolysis of glycoside conjugates is a 
critical step in absorption of polyphenols in the small intestine, following which corresponding 
aglycones appear in the intestinal cells. In the intestinal cells, these aglycones are further 
subjected to an initial phase II metabolism, resulting in appearance of sulfate, glucuronide or 
methyl metabolites. These metabolites enter the circulation and reach the liver, where their phase 
II metabolism continues; only a small amount is transported back to the lumen of the small 
intestine, eventually reaching the large intestine. Therefore, after the absorption in the small 
intestine, polyphenol phase II metabolites are predominantly found in the circulation(71), whereas 
the appearance of parent compounds, such as (-)-epicatechin-3-O-gallate and (-)-
epigallocatechin-3-O-gallate is practically an exception of the general rule. Post-absorption 
plasma concentrations of phase II metabolites are low, reflecting the low bioavailability of 
polyphenols, which is further emphasized by their rapid urinary excretion. Plethora of enzymes 
and transporters are involved in the processes of hydrolysis, absorption, phase II metabolism and 
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renal excretion of polyphenols(67). Theoretically, polymorphisms in the genes that code these 
proteins may be involved in the ADME component of the overall inter-individual variability in 
response to consumption of nutritional polyphenols. Indeed, it has been demonstrated that 
COMT (catechol-O-methyltransferase; enzyme that catalyzes methylation of nutritional 
polyphenols in the human body) genotype (rs4680) may determine the health benefits from green 
tea intake(72). However, the existing data is limited, and genetic factors, along with the influence 
of gut microbiota, should be addressed in more detail future studies(73). 
Indeed, only a small portion of the nutritional polyphenols are absorbed in the small intestine, 
while most of them reach the large intestine where they are subjected to extensive metabolism. 
Gut microbiota plays an important role in the metabolism of nutritional polyphenols, which 
results in appearance of plethora of gut microbiota metabolites, such as aglycones, small 
phenolic acids and valerolactones. Some of these molecules are absorbed in the large intestine, 
and are further metabolized in the liver. There is strong scientific evidence that gut microbiota 
metabolites are among the key mediators of the (cardiometabolic) health promoting effects of 
polyphenols(74,75). In addition, with identification of different metabotypes(76,77), gut microbiota 
has been pinpointed as one of the determinants of inter-individual variability in response to 
consumption of polyphenols. 
2.3 Molecular mechanisms involved in the antioxidant effects of polyphenols, and beyond 
With evolution of our understanding of oxidative stress (see section 1.1) and elucidation of the 
complex metabolism of polyphenols in the human body (section 2.2), the concept that health 
promoting effects of polyphenols are mediated solely by their ability to scavenge free radicals in 
vivo has been abandoned. Indeed, it has been clarified that polyphenol metabolites do not 
scavenge substantial amount of free radicals in vivo, and that α-tocopherol is the key compound 
that terminates the chain reaction of lipid peroxidation. Hence, summarizing the latest scientific 
evidence from both fields, the major mechanism by which polyphenols contribute to the cellular 
antioxidant defense has been proposed recently(78). Namely, after consumption, low 
concentrations of mainly metabolized polyphenols reach the cells. Some of them, such as 
catechin, epicatechin, hydroxytyrosol, delphinidin and carnosic acid are oxidized by free 
radicals, in free radical scavenging reactions. An important target of the oxidized polyphenols is 
Keap1 (Kelch Like ECH Associated Protein 1), a cytosolic protein whose function is to regulate 
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the activity of transcription factor Nrf2 (Nuclear Factor, Erythroid 2 Like 2). Some polyphenols, 
such as resveratrol and curcumin, bind with Keap1 directly, without prior oxidation. The 
regulatory function of Keap1 consists of assistance in ubiquitination of Nrf2, which results in its 
degradation by proteasome. After binding a polyphenolic compound, Keap1 is inactivated, and 
the half-life of Nrf2 is extended. Therefore, Nrf2 migrates to the nucleus, binds to the ARE – 
Antioxidant Response Element (also known as EpRE – Electrophile Response Element), and 
initiate the transcription of genes that are involved in the antioxidant defense and detoxification. 
Besides Nrf2, other transcription factors, such as c-Maf, c-Jun, c-Fos, Fra1, Bach1, Nrf1 or c-
Myc are also involved in the ARE-mediated transcription, in a complex interplay. In addition, 
there is evidence that protein kinases, such as PKC or PI3K play role in the phosphorylation of 
Nrf2, which is a critical step for its translocation to the nucleus. Recent findings that polyphenol 
metabolites have potential to modulate kinases’ activities are indicative of multilevel regulation 
of Nrf2-mediated transcription. 
Besides the Keap1/Nrf2/ARE pathway, nutritional polyphenols also modulate a plethora of 
cellular functions that are not directly connected with the enzymatic antioxidant defense, but are 
still very closely associated with the subtle regulation of cellular redox balance. Related to the 
cardiometabolic health, the effects of polyphenols on cellular processes that are involved in 
chronic inflammation, endothelial dysfunction, impaired insulin signaling, adipose tissue 
remodeling or mitochondrial dysfunction have been reviewed in detail(79-82). Similar to what has 
been demonstrated for Keap1, there is growing body of scientific evidence that molecular 
mechanisms of health promoting effects of polyphenols involve their binding to specific 
proteins, and subsequent effects on cell signaling. For instance, in silico docking analyses 
revealed that curcumin also has ability to bind to some kinases, such as TAK1, PDK1, AKT1 
and AKT2, which are involved in regulation of the redox-sensitive pro-inflammatory 
transcription factor NF-κB. Indeed, NF-κB is established as a key mediator of inflammation, 
which is a common underlying mechanism of cardiometabolic diseases. Accordingly, a pre-
exposure of human umbilical vein endothelial cells (HUVECs) to curcumin (1 µM) prior to 
TNFα stimulation, attenuates the activation of NF-κB. In parallel, curcumin decreases monocyte 
adhesion and transendothelial migration, and modulates the expression of genes involved in 
antioxidant defense, metabolism, cell signaling, focal adhesion, intercellular junction and 
cytoskeleton organization(83), which is altogether pertinent to an improved endothelial function. 
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Similarly, it has been demonstrated that pre-exposure of HUVECs to physiologically relevant 
concentrations of plasma anthocyanins’ metabolites (including their gut microbiota metabolites), 
also decreases the TNFα-induced monocyte cell adhesion. Gene expression analysis 
demonstrated modulation of genes that are involved in cell adhesion, leucocyte transendothelial 
migration, regulation of actin cytoskeleton or NF-κB signaling. Subsequent bioinformatic 
analysis and in silico docking demonstrated that anthocyanins’ metabolites can bind to several 
cell signaling proteins, including MEK2 and IKKα, and potentially modulate their activity. The 
results of in silico docking were confirmed with Western blot analysis, demonstrating a 
decreased phosphorylation of ERK and p65 unit of NF-κB, pertinent to the modulation of 
upstream kinases, and the degreased leucocyte transendothelial migration and inflammation(84). 
In addition, it has been demonstrated that flavanol colonic metabolites activate eNOS in human 
endothelial cells via AKT and AMPK signaling, and increase intracellular nitric oxide, which 
plays a pivotal role in regulation of endothelial function(85). An integrated systems biology 
approach has been taken recently to elucidate the multi-target and multi-layer cellular effects of 
circulating epicatechin metabolites on endothelial cells, demonstrating modulation in gene and 
miRNA expressions, and DNA methylation. In silico docking demonstrated favorable binding of 
epicatechin metabolites to p38-MAPK, which regulates several transcription factors such as NF-
κB, CREB1, c-MYC, c-JUN, STAT3 or SP1(86). 
Molecular mechanisms of the effects of polyphenols on cardiometabolic health have also been 
studied in other relevant cell models, such as immune cells, adipocytes, hepatocytes, smooth 
muscle cells and β-cells. Aiming to systematize the current scientific evidence, we recently 
extracted and analyzed the nutrigenomic data related to the effects of flavanols or their 
circulating metabolites in these cell models (paper under submission). Thereby, it was noticed 
that in large number of studies the cells were exposed to plant extracts or high concentrations of 
pure compounds, which are not physiologically relevant(73). This knowledge gap needs to be 
addressed in future, in order to better understand the molecular mechanisms of health promoting 
effects of polyphenols. 
Regarding the contribution of nutritional polyphenols to the cellular antioxidant defense, an 
important consideration is that they are present in the cells at low concentrations. Therefore, they 
cannot scavenge a significant amount of free radicals. Instead, they modulate transcription of the 
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genes involved in antioxidant defense and detoxification. On the other hand, if present at high 
concentrations, polyphenols may induce toxicity. These considerations are integrated in the 
concept of hormesis(87), which also applies to nutritional polyphenols(88). Potential toxicity of 
high doses of polyphenols should be always kept in mind, as over-the-counter supplements (such 
as resveratrol, curcumin, quercetin or various plant extracts) are widely available. The lesson 
learned from the antioxidant supplementation studies that “natural” does not always mean “safe 
in high doses”, should be well remembered. As new strategies to increase the bioavailability of 
polyphenols are developing rapidly(89), safety and toxicity should be carefully investigated. The 
topic of safety and toxicity(90) becomes even more important when we take into account the inter-
individual variability in response, which will be discussed in the following sections. 
3. Effects of polyphenols on cardiometabolic health and cardiometabolic risk factors 
3.1 Human intervention studies 
Following the pioneering study of Hertog et al.(59), which demonstrated an inverse association 
between flavonoid intake and mortality from coronary heart disease, numerous human studies 
have been conducted to explore the impact of consumption of polyphenols on cardiometabolic 
health. In this type of studies, specific biomarkers should be clearly identified and precisely 
measured. It is above the scope of this review to analyze in detail this large body of scientific 
evidence. Therefore, in this paper we present only several relevant human studies (Table 1). 
“Cardiometabolic” is a relatively new term that encompasses a wide spectrum of cardiovascular 
and metabolic diseases, including coronary heart disease, non-alcoholic fatty liver disease, 
metabolic syndrome and type 2 diabetes. These diseases are the leading cause of morbidity and 
mortality worldwide. They all share common risk factors such as overweight/obesity, 
inflammation, increased blood pressure, and dyslipidemia(91). Knowing that diet and life-style 
largely determine the risk for cardiometabolic diseases, one of the main goals in promoting the 
cardiometabolic health is development of preventive health programs, such as adoption of 
healthy dietary habits by the majority of population. Moreover, personalized nutrition could be 
an effective strategy for prevention and treatment of cardiometabolic diseases in future, either at 
larger population groups or at individual level. 
Cardioprotective effects of polyphenols have been extensively studied. In an acute study(92), it 
has been demonstrated that flavonoid-rich apple improves plasma nitric oxide status and 
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endothelial function (measured as flow-mediated dilatation – FMD) and lowers systolic blood 
pressure. These outcomes are among the most important determinants of cardiovascular health. 
One of the most convincing evidence for cardioprotective effects of dietary flavonoids has also 
been related to their beneficial effects on endothelial function, as demonstrated in a meta-
analysis conducted in 2008(93). In that sense, the most convincing effect was observed for cocoa 
flavonoids. Polyphenols have been pointed out as a promising nutritional approach for 
prevention and treatment of hypertension. Indeed, a large cross-sectional study demonstrated a 
negative correlation between total polyphenol intake and blood pressure, both systolic and 
diastolic(94). Similarly, regular consumption of cocoa product rich in cocoa fiber significantly 
decreased the systolic and diastolic blood pressure in moderately hypercholesterolemic 
humans(95). Another important determinant of cardiovascular (and more broadly, 
cardiometabolic) health is the level of systemic inflammation of low intensity, which is clinically 
assessed using plasma C-reactive protein as a biomarker, preferably with a method of high 
sensitivity (hs-CRP). In that sense, a recent meta-analysis of RCTs demonstrated that resveratrol 
significantly decreases serum CRP levels(96), thus potentially decreasing the cardiovascular risk. 
Cardioprotective effects of nutritional polyphenols are also mediated through their beneficial 
influence on circulating lipoproteins. As such, nutritional polyphenols exhibit a potential to 
decrease the atherogenic risk. The effect of epigallocatechin gallate (EGCG) on LDL-cholesterol 
was summarized in a recent systematic review, demonstrating a significant reduction of plasma 
LDL-cholesterol in healthy individuals with EGCG intake between 107 and 856 mg/day(97). It 
has also been demonstrated that regular consumption of cocoa increases HDL-cholesterol and 
decreases oxidized LDL in elderly at high risk for cardiovascular disease(98). Similarly, regular 
consumption of flavanol-rich cocoa products has been found to increase HDL-cholesterol in both 
normocholesterolemic and moderately hypercholesterolemic free-living subjects(99,100). In 
addition, increase in HDL-cholesterol and decrease in plasma oxidized LDL is linear with the 
phenolic content of olive oil(101). Dyslipidemia and oxidative stress, which are well-defined risk 
factors for atherosclerosis, are also decreased by diet containing products naturally rich in 
polyphenols(102). 
Effects of dietary polyphenols on the metabolic component of the cardiometabolic risk factors 
have also been explored by many researchers. Indeed, the beneficial effects of dietary 
D
ow
nloaded from
 https://w
w
w
.cam
bridge.org/core . IN
RA
 - Versailles-G
rignon , on 06 N
ov 2019 at 15:09:33 , subject to the C
am
bridge C
ore term
s of use, available at https://w
w
w
.cam
bridge.org/core/term
s . https://doi.org/10.1017/S0007114519002733
Accepted manuscript 
16 
polyphenols on insulin sensitivity, glucose tolerance and insulin secretion may potentially 
decrease the risk of type 2 diabetes. In that sense, it has been demonstrated that strawberry and 
cranberry polyphenols improve insulin sensitivity in overweight and obese non-diabetic, insulin-
resistant persons(103), and that polyphenols in general decrease blood glucose response during the 
oral glucose tolerance test in individuals at high cardiometabolic risk(104). Consumption of 
flavanol-rich dark chocolate(105), and supplementation with epicatechin(106) improve insulin 
sensitivity in healthy subjects. Importantly, numerous epidemiological studies and RCTs have 
demonstrated that consumption of green tea, red wine and cocoa lowers the risk of type 2 
diabetes(107). In addition, higher consumption of anthocyanins and anthocyanin-rich fruit has also 
been associated with lower risk of type 2 diabetes(108). 
Accumulated scientific evidence about the effects of cocoa flavanols and polyphenols in olive on 
specific aspects of human health was analyzed by EFSA (European Food Safety Authority) 
Panel on Dietetic Products, Nutrition and Allergies. Regarding the cocoa flavanols(109,110), the 
Panel endorses the health claim that they “help maintain endothelium-dependent vasodilatation 
which contributes to healthy blood flow”(110), and regarding the polyphenols in olive, the Panel 
endorses that “consumption of olive oil polyphenols contributes to the protection of blood lipids 
from oxidative damage”(111). Notably, although many human intervention studies demonstrated 
beneficial effects of polyphenols on cardiometabolic health, and predominantly on 
cardiometabolic risk factors, there are also studies that reported lack of expected outcomes. For 
example, red wine polyphenols did not improve obesity-associated insulin resistance(112), and 
regular consumption of polyphenol-rich apple failed to influence endothelial function in 
hypercholesterolemic adults(113). Considering these and other similar findings, it is essential to 
understand that many aspects should be taken into account in order to predict the effects of 
dietary polyphenols on cardiometabolic health. The chemical variety of polyphenols, as well as 
the variety of their nutritional sources and food matrices largely influence the effects of 
polyphenols in humans. In addition, the inter-individual variability in bioavailability (which is 
governed by ADME), as well as the inter-individual variability in bioactivity of (the 
bioavailable) dietary polyphenols, undoubtedly play pivotal role(114). Besides, the inconsistency 
of results from human studies might be influenced, at least in part, by the heterogeneity of study 
populations, study designs and intervention periods. 
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3.2 Inter-individual variability in response to consumption of polyphenols 
Ideally, dietary recommendations for intake of polyphenols (and plant food bioactives in general) 
should be determined by their: a) bioavailability and b) bioactivity, taking into account the inter-
individual variability. In the first place, the inter-individual variability of ADME affects the 
bioavailability of polyphenols. Further, the bioactivity of the bioavailable polyphenols (and/or 
their metabolites) is most likely additionally affected by the inter-individual variability of their 
cellular molecular metabolism in the target tissues, as well as the inter-individual variability of 
the cellular processes they modulate. All these factors together affect the inter-individual 
variability in response to consumption of polyphenols. Furthermore, age, gender, health status, 
genetics and epigenetic factors have been suggested as the main determinants of the inter-
individual variability of response(115). However, the specific contribution of each of these factors 
is not completely understood. Indeed, we are at the very early stage of the research in this field. 
The information we currently have about the inter-individual variability was mainly generated 
during the post-hoc analyses, not from the studies that had initially been designed to study this 
subject. This issue should be well addressed in future. 
To obtain more information about the inter-individual variability in cardiometabolic response of 
consumption of nutritional polyphenols, four meta-analyses were conducted recently, using the 
available data from the literature. The meta-analysis of the cardiometabolic health effects of 
flavonols confirmed that they improve plasma lipid status, decrease systolic and diastolic blood 
pressure, and plasma glucose. Deeper study of the available data, aiming to address the inter-
individual variability, demonstrated that these effects are more pronounced in participants with 
diagnosed disease or dyslipidemia(116). The meta-analysis on flavanols also confirmed that they 
beneficially modulate several cardiometabolic risk factors, such as plasma lipids, body mass 
index and waist circumference. However, higher efficacy was demonstrated in the participants 
with body mass index ≥ 25 kg/m2 and in non-medicated individuals, revealing the inter-
individual variability(117). Similarly, the beneficial effects of ellagitannins and anthocyanins on 
selected cardiometabolic risk factors were found to be more prominent in overweight and obese 
subjects(118), and the effects of hydroxycinnamic acids may be greater in individuals at higher 
cardiometabolic risk(119). 
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These meta-analyses are of high importance because they introduce and emphasize the 
significance of the inter-individual variability in response to consumption of dietary polyphenols 
to the scientific community. However, their main limitations were the following: a) 
unavailability of individual data, pre- and post-intervention, and b) low number of studies. 
Importantly, even though facing these limitations, the authors were able to demonstrate 
significant inter-individual variability of several crucial cardiometabolic risk factors, which 
opens perspectives for further research in the field. However, in order to be able to conduct more 
robust meta-analyses in future, availability of individual data should be encouraged, of course in 
compliance with ethical standards. Understanding the factors that determine the inter-individual 
variability in response to consumption of polyphenols will lead us towards tailoring of 
personalized dietary recommendations, at both population group and individual level. 
Conclusion and perspective 
In this review, we aim to address the key aspects of the impact of polyphenols on human 
cardiometabolic health, historically and in perspective, as summarized in Figure 1. Historically, 
there was a tendency to attribute the positive effects of polyphenols on human cardiometabolic 
health exclusively to their free radical scavenging capacity. Nowadays we understand that they 
express their antioxidant activity mainly through modulation of transcription of genes involved 
in antioxidant defense and detoxification. Apart from their antioxidant activity, polyphenols also 
contribute to the cardiometabolic health by modulating plethora of cellular processes that are not 
directly associated with the antioxidant enzymes, which are subject to extensive research. In the 
cells, dietary polyphenols and/or their metabolites are present at low concentrations. 
Administered at very high concentrations, polyphenols may cause toxic effects in humans. 
Informed about the beneficial effects of polyphenols on human cardiometabolic health, the 
temptation among the general population for taking supplements of pure compounds or plant 
extracts, which are readily available as over-the-counter pharmaceutical forms, is realistic. 
However, the vigilance for their potential toxicity, if taken at high doses, should remain high. 
Growing scientific evidence demonstrates the beneficial effects of dietary polyphenols on human 
cardiometabolic health. Numerous randomized controlled trials report improvement of the key 
biomarkers of cardiometabolic health such as blood pressure, flow-mediated dilatation, blood 
lipids, blood glucose, and insulin sensitivity. The inconsistency of the results of some studies 
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triggered interest towards post-hoc analysis of individual data, which led to identification of the 
inter-individual variability in the response. Resolving the puzzle of the inter-individual 
variability will lead us towards personalized dietary recommendations, with ultimate goal to 
decrease the risk for cardiometabolic diseases and preserve the health for better aging. For this 
purpose, future studies shall be specifically designed to address the various aspects of the inter-
individual variability in response to consumption of polyphenols, and plant food bioactives in 
general. 
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Figure 1. Polyphenols in human diet – in vitro and in vivo. 
 
D
ow
nloaded from
 https://w
w
w
.cam
bridge.org/core . IN
RA
 - Versailles-G
rignon , on 06 N
ov 2019 at 15:09:33 , subject to the C
am
bridge C
ore term
s of use, available at https://w
w
w
.cam
bridge.org/core/term
s . https://doi.org/10.1017/S0007114519002733
Accepted manuscript 
21 
References 
1. Anderson AS (2007) Nutrition interventions in women in low-income groups in the UK. Proc 
Nutr Soc 66(1), 25-32. 
2. Dammann KW & Smith C (2009) Factors affecting low-income women's food choices and the 
perceived impact of dietary intake and socioeconomic status on their health and weight. J Nutr 
Educ Behav 41(4), 242-253. 
3. Barker M, Lawrence W, Crozier S et al. (2009) Educational attainment, perceived control and 
the quality of women's diets. Appetite 52(3), 631-636. 
4. Grosso G, Stepaniak U, Micek A et al. (2017) Dietary polyphenol intake and risk of type 2 
diabetes in the Polish arm of the Health, Alcohol and Psychosocial factors in Eastern Europe 
(HAPIEE) study. Br J Nutr 118(1), 60-68. 
5. Medina-Remon A, Casas R, Tressserra-Rimbau A et al. (2017) Polyphenol intake from a 
Mediterranean diet decreases inflammatory biomarkers related to atherosclerosis: a sub study of 
the PREDIMED trial. Br J Clin Pharmacol 83(1), 114-128. 
6. Sawikr Y, Yarla NS, Peluso I et al. (2017) Neuroinflammation in Alzheimer's disease: the 
preventive and therapeutic potential of polyphenolic nutraceuticals. Adv Protein Chem Struct 
Biol 108, 33-57. 
7. Costa C, Tsatsakis A, Mamoulakis C et al. (2017) Current evidence on the effect of dietary 
polyphenols intake on chronic diseases. Food Chem Toxicol 110, 286-299. 
8. Salah N, Miller NJ, Paganga G et al. (1995) Polyphenolic flavanols as scavengers of aqueous 
phase radicals and as chain-breaking antioxidants. Arch Biochem Biophys 322(2), 339-346. 
9. Visioli F, Bellomo G, Galli C (1998) Free radical-scavenging properties of olive oil 
polyphenols. Biochem Biophys Res Commun 247(1), 60-64. 
10. Vinson JA (1998) Flavonoids in foods as in vitro and in vivo antioxidants. Adv Exp Med Biol 
439, 151-164. 
D
ow
nloaded from
 https://w
w
w
.cam
bridge.org/core . IN
RA
 - Versailles-G
rignon , on 06 N
ov 2019 at 15:09:33 , subject to the C
am
bridge C
ore term
s of use, available at https://w
w
w
.cam
bridge.org/core/term
s . https://doi.org/10.1017/S0007114519002733
Accepted manuscript 
22 
11. Miura Y, Chiba T, Miura S et al. (2000) Green tea polyphenols (flavan 3-ols) prevent 
oxidative modification of low density lipoproteins: an ex vivo study in humans. J Nutr Biochem 
11(4), 216-222. 
12. Hernaez A, Remaley AT, Farras M et al. (2015) Olive oil polyphenols decrease LDL 
concentrations and LDL atherogenicity in men in a randomized controlled trial. J Nutr 145(8), 
1692-1697. 
13. Kehrer JP & Klotz LO (2015) Free radicals and related reactive species as mediators of tissue 
injury and disease: implications for health. Crit Rev Toxicol 45(9), 765-798. 
14. Harman D (1956) Aging: a theory based on free radical and radiation chemistry. J Gerontol 
11(3), 298-300. 
15. Paniker NV, Srivastava SK, Beutler E (1970) Glutathione metabolism of the red cells. Effect 
of glutathione reductase deficiency on the stimulation of hexose monophosphate shunt under 
oxidative stress. Biochim Biophys Acta 215(3), 456-460. 
16. Sies H (1985) Oxidative Stress: Introductory Remarks. In Oxidative Stress, pp. 1-8 [H Sies, 
editor]. Academic Press, Elsevier Ltd. 
17. Sies H & Cadenas E (1985) Oxidative stress: damage to intact cells and organs. Philos Trans 
R Soc Lond B Biol Sci 311(1152), 617-631. 
18. Jones DP (2006) Redefining oxidative stress. Antioxid Redox Signal 8(9-10), 1865-1879. 
19. Jones DP (2008) Radical-free biology of oxidative stress. Am J Physiol Cell Physiol 295(4), 
C849-C868. 
20. Sies H (2019) Oxidative Stress: Eustress and Distress in Redox Homeostasis. In Stress: 
Physiology, Biochemistry, and Pathology, pp. 153-163 [G Fink, editor]. Academic Press, 
Elsevier Ltd. 
21. Birben E, Sahiner UM, Sackesen C et al. (2012) Oxidative stress and antioxidant defense. 
World Allergy Organ J 5(1), 9-19. 
22. Zimniak P (2011) Relationship of electrophilic stress to aging. Free Radic Biol Med 51(6), 
1087-1105. 
D
ow
nloaded from
 https://w
w
w
.cam
bridge.org/core . IN
RA
 - Versailles-G
rignon , on 06 N
ov 2019 at 15:09:33 , subject to the C
am
bridge C
ore term
s of use, available at https://w
w
w
.cam
bridge.org/core/term
s . https://doi.org/10.1017/S0007114519002733
Accepted manuscript 
23 
23. Cipak Gasparovic A, Zarkovic N, Zarkovic K et al. (2017) Biomarkers of oxidative and 
nitro-oxidative stress: conventional and novel approaches. Br J Pharmacol 174(12), 1771-1783. 
24. Ruskovska T & Bernlohr DA (2013) Oxidative stress and protein carbonylation in adipose 
tissue - implications for insulin resistance and diabetes mellitus. J Proteomics 92, 323-334. 
25. Gueraud F, Atalay M, Bresgen N et al. (2010) Chemistry and biochemistry of lipid 
peroxidation products. Free Radic Res 44(10), 1098-1124. 
26. Tsuchihashi H, Kigoshi M, Iwatsuki M et al. (1995) Action of beta-carotene as an 
antioxidant against lipid peroxidation. Arch Biochem Biophys 323(1), 137-147. 
27. Spiteller G (2002) Are changes of the cell membrane structure causally involved in the aging 
process? Ann N Y Acad Sci 959, 30-44. 
28. Jiang Q, Christen S, Shigenaga MK et al. (2001) Gamma-tocopherol, the major form of 
vitamin E in the US diet, deserves more attention. Am J ClinNutr 74(6), 714-722. 
29. Kurutas EB (2016) The importance of antioxidants which play the role in cellular response 
against oxidative/nitrosative stress: current state. Nutr J 15(1), 71. 
30. Niki E (2014) Role of vitamin E as a lipid-soluble peroxyl radical scavenger: in vitro and in 
vivo evidence. Free Radic Biol Med 66, 3-12. 
31. Bjelakovic G, Nikolova D, Gluud LL et al. (2008) Antioxidant supplements for prevention of 
mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev 
2, CD007176. 
32. Bjelakovic G, Nikolova D, Gluud LL et al. (2012) Antioxidant supplements for prevention of 
mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev 
3, CD007176. 
33. Ghezzi P, Jaquet V, Marcucci F et al. (2017) The oxidative stress theory of disease: levels of 
evidence and epistemological aspects. Br J Pharmacol 174(12), 1784-1796. 
34. Milkovic L, Gasparovic AC, Zarkovic N (2015) Overview on major lipid peroxidation 
bioactive factor 4-hydroxynonenal as pluripotent growth-regulating factor. Free Radic Res 49(7), 
850-860. 
D
ow
nloaded from
 https://w
w
w
.cam
bridge.org/core . IN
RA
 - Versailles-G
rignon , on 06 N
ov 2019 at 15:09:33 , subject to the C
am
bridge C
ore term
s of use, available at https://w
w
w
.cam
bridge.org/core/term
s . https://doi.org/10.1017/S0007114519002733
Accepted manuscript 
24 
35. Chen ZH, Saito Y, Yoshida Y et al. (2005) 4-Hydroxynonenal induces adaptive response and 
enhances PC12 cell tolerance primarily through induction of thioredoxin reductase 1 via 
activation of Nrf2. J Biol Chem 280(51), 41921-41927. 
36. Azzi A (2018) Many tocopherols, one vitamin E. Mol Aspects Med 61, 92-103. 
37. von Lintig J (2012) Provitamin A metabolism and functions in mammalian biology. Am J 
Clin Nutr 96(5), 1234S-1244S. 
38. Vrolijk MF, Opperhuizen A, Jansen EH et al. (2015) The shifting perception on antioxidants: 
the case of vitamin E and β-carotene. Redox Biol 4, 272-278. 
39. Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group (1994) The effect of 
vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. 
N Engl J Med 330(15), 1029-1035. 
40. Niki E (2014) Antioxidants: basic principles, emerging concepts, and problems. Biomed J 
37(3), 106-11. 
41. Sanyal AJ, Chalasani N, Kowdley KV et al. (2010) NASH CRN. Pioglitazone, vitamin E, or 
placebo for nonalcoholic steatohepatitis. N Engl J Med 362(18), 1675-1685. 
42. Vardi M, Levy NS, Levy AP (2013) Vitamin E in the prevention of cardiovascular disease: 
the importance of proper patient selection. J Lipid Res 54(9), 2307-2314. 
43. Ruskovska T, Pop-Kostova A, Jansen EHJM et al. (2017) Vitamin E supplementation in 
chronically hemodialyzed patients - influence on blood hemoglobin and plasma (anti)oxidant 
status. Int J Vitam Nutr Res 87(3-4), 139-148. 
44. Ahmad KA, Yuan Yuan D, Nawaz W et al. (2017) Antioxidant therapy for management of 
oxidative stress induced hypertension. Free Radic Res 51(4), 428-438. 
45. Abner EL, Schmitt FA, Mendiondo MS et al. (2011) Vitamin E and all-cause mortality: a 
meta-analysis. Curr Aging Sci 4(2), 158-170. 
46. Curtis AJ, Bullen M, Piccenna L et al. (2014) Vitamin E supplementation and mortality in 
healthy people: a meta-analysis of randomised controlled trials. Cardiovasc Drugs Ther 28(6), 
563-73. 
D
ow
nloaded from
 https://w
w
w
.cam
bridge.org/core . IN
RA
 - Versailles-G
rignon , on 06 N
ov 2019 at 15:09:33 , subject to the C
am
bridge C
ore term
s of use, available at https://w
w
w
.cam
bridge.org/core/term
s . https://doi.org/10.1017/S0007114519002733
Accepted manuscript 
25 
47. Jansen E & Ruskovska T (2015) Serum biomarkers of (anti)oxidant status for 
epidemiological studies. Int J Mol Sci. 16(11), 27378-27390. 
48. Frijhoff J, Winyard PG, Zarkovic N et al. (2015) Clinical relevance of biomarkers of 
oxidative stress. Antioxid Redox Signal 23(14), 1144-1170. 
49. Kurin E, Mucaji P, Nagy M (2012) In vitro antioxidant activities of three red wine 
polyphenols and their mixtures: an interaction study. Molecules 17(12), 14336-14348. 
50. Erben-Russ M, Bors W, Saran M (1987) Reactions of linoleic acid peroxyl radicals with 
phenolic antioxidants: a pulse radiolysis study. Int J Radiat Biol Relat Stud Phys Chem Med 
52(3), 393-412. 
51. Siti HN, Kamisah Y, Kamsiah J (2015) The role of oxidative stress, antioxidants and 
vascular inflammation in cardiovascular disease (a review). Vascul Pharmacol 71, 40-56. 
52. Gonzalez S, Fernandez M, Cuervo A et al. (2014) Dietary intake of polyphenols and major 
food sources in an institutionalised elderly population. J Hum Nutr Diet 27(2), 176-183. 
53. Miranda AM, Steluti J, Fisberg RM et al. (2016) Dietary intake and food contributors of 
polyphenols in adults and elderly adults of Sao Paulo: a population-based study. Br J Nutr 
115(6), 1061-1070. 
54. Grosso G, Stepaniak U, Topor-Mądry R et al. (2014) Estimated dietary intake and major 
food sources of polyphenols in the Polish arm of the HAPIEE study. Nutrition 30(11-12), 1398-
1403. 
55. Scalbert A & Williamson G (2000) Dietary intake and bioavailability of polyphenols. J Nutr 
130(8S), 2073S-2085S. 
56. Pandey KB & Rizvi SI (2009) Plant polyphenols as dietary antioxidants in human health and 
disease. Oxid Med Cell Longev 2(5), 270-278. 
57. Neveu V, Perez-Jimenez J, Vos F et al. (2010) Phenol-Explorer: an online comprehensive 
database on polyphenol contents in foods. Database (Oxford) 2010, bap024. http://www.phenol-
explorer.eu (accessed March 2019). 
D
ow
nloaded from
 https://w
w
w
.cam
bridge.org/core . IN
RA
 - Versailles-G
rignon , on 06 N
ov 2019 at 15:09:33 , subject to the C
am
bridge C
ore term
s of use, available at https://w
w
w
.cam
bridge.org/core/term
s . https://doi.org/10.1017/S0007114519002733
Accepted manuscript 
26 
58. Bhagwat S, Haytowitz DB, Holden JM (ret.) (2014) USDA Database for the Flavonoid 
Content of Selected Foods, Release 3.1. U.S. Department of Agriculture, Agricultural Research 
Service. http://www.ars.usda.gov/nutrientdata/flav (accessed March 2019). 
59. Hertog MG, Feskens EJ, Hollman PC et al. (1993) Dietary antioxidant flavonoids and risk of 
coronary heart disease: the Zutphen Elderly Study. Lancet 342(8878), 1007-1011. 
60. U.S. Department of Agriculture, Agricultural Research Service (2010) USDA Database for 
the Oxygen Radical Absorbance Capacity (ORAC) of Selected Foods, Release 2. 
61. Prior RL, Hoang H, Gu L et al. (2003). Assays for hydrophilic and lipophilic antioxidant 
capacity (oxygen radical absorbance capacity (ORAC(FL))) of plasma and other biological and 
food samples. J Agric Food Chem 51(11), 3273-3279. 
62. Gillespie KM, Chae JM, Ainsworth EA (2007) Rapid measurement of total antioxidant 
capacity in plants. Nat Protoc 2(4), 867-870. 
63. Litescu SC, Eremia S, Radu GL (2010) Methods for the determination of antioxidant 
capacity in food and raw materials. Adv Exp Med Biol 698, 241-249. 
64. https://www.usda.gov/ (accessed March 2019). 
65. Manach C, Williamson G, Morand C et al. (2005) Bioavailability and bioefficacy of 
polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81(1S), 230S-
242S. 
66. Halliwell B, Zhao K, Whiteman M (2000) The gastrointestinal tract: a major site of 
antioxidant action? Free Radic Res 33(6), 819-830. 
67. Del Rio D, Rodriguez-Mateos A, Spencer JP et al. (2013) Dietary (poly)phenolics in human 
health: structures, bioavailability, and evidence of protective effects against chronic diseases. 
Antioxid Redox Signal 18(14), 1818-1892. 
68. Lotito SB, Zhang WJ, Yang CS et al. (2011) Metabolic conversion of dietary flavonoids 
alters their anti-inflammatory and antioxidant properties. Free Radic Biol Med 51(2), 454-463. 
D
ow
nloaded from
 https://w
w
w
.cam
bridge.org/core . IN
RA
 - Versailles-G
rignon , on 06 N
ov 2019 at 15:09:33 , subject to the C
am
bridge C
ore term
s of use, available at https://w
w
w
.cam
bridge.org/core/term
s . https://doi.org/10.1017/S0007114519002733
Accepted manuscript 
27 
69. Loke WM, Proudfoot JM, Stewart S et al. (2008) Metabolic transformation has a profound 
effect on anti-inflammatory activity of flavonoids such as quercetin: lack of association between 
antioxidant and lipoxygenase inhibitory activity. Biochem Pharmacol 75(5), 1045-1053. 
70. Williamson G & Clifford MN (2017) Role of the small intestine, colon and microbiota in 
determining the metabolic fate of polyphenols. Biochem Pharmacol 139, 24-39. 
71. Mullen W, Edwards CA, Crozier A (2006) Absorption, excretion and metabolite profiling of 
methyl-, glucuronyl-, glucosyl- and sulpho-conjugates of quercetin in human plasma and urine 
after ingestion of onions. Br J Nutr 96(1), 107-116. 
72. Inoue-Choi M, Yuan JM, Yang CS et al. (2010) Genetic association between the COMT 
genotype and urinary levels of tea polyphenols and their metabolites among daily green tea 
drinkers. Int J Mol Epidemiol Genet 1(2), 114-123. 
73. Gibney ER, Milenkovic D, Combet E et al. (2019) Factors influencing the cardiometabolic 
response to (poly)phenols and phytosterols: a review of the COST Action POSITIVe activities. 
Eur J Nutr Published online: 6 September 2019. doi: 10.1007/s00394-019-02066-6. 
74. Kawabata K, Yoshioka Y, Terao J (2019) Role of intestinal microbiota in the bioavailability 
and physiological functions of dietary polyphenols. Molecules 24(2), pii: E370. 
75. Fernandez-Millan E, Ramos S, Alvarez C et al. (2014) Microbial phenolic metabolites 
improve glucose-stimulated insulin secretion and protect pancreatic beta cells against tert-butyl 
hydroperoxide-induced toxicity via ERKs and PKC pathways. Food Chem Toxicol 66, 245-253. 
76. Gonzalez-Sarrias A, Garcia-Villalba R, Romo-Vaquero M et al. (2017) Clustering according 
to urolithin metabotype explains the interindividual variability in the improvement of 
cardiovascular risk biomarkers in overweight-obese individuals consuming pomegranate: A 
randomized clinical trial. Mol Nutr Food Res 61(5). 
77. Hazim S, Curtis PJ, Schar MY et al. (2016) Acute benefits of the microbial-derived 
isoflavone metabolite equol on arterial stiffness in men prospectively recruited according to 
equol producer phenotype: a double-blind randomized controlled trial. Am J Clin Nutr 103(3), 
694-702. 
D
ow
nloaded from
 https://w
w
w
.cam
bridge.org/core . IN
RA
 - Versailles-G
rignon , on 06 N
ov 2019 at 15:09:33 , subject to the C
am
bridge C
ore term
s of use, available at https://w
w
w
.cam
bridge.org/core/term
s . https://doi.org/10.1017/S0007114519002733
Accepted manuscript 
28 
78. Forman HJ, Davies KJ, Ursini F (2014) How do nutritional antioxidants really work: 
nucleophilic tone and para-hormesis versus free radical scavenging in vivo. Free Radic Biol Med 
66, 24-35. 
79. Krga I, Milenkovic D, Morand C et al. (2016) An update on the role of nutrigenomic 
modulations in mediating the cardiovascular protective effect of fruit polyphenols. Food Funct 
7(9), 3656-3676. 
80. Kim HS, Quon MJ, Kim JA (2014) New insights into the mechanisms of polyphenols beyond 
antioxidant properties; lessons from the green tea polyphenol, epigallocatechin 3-gallate. Redox 
Biol 2,187-195. 
81. Goszcz K, Duthie GG, Stewart D et al. (2017) Bioactive polyphenols and cardiovascular 
disease: chemical antagonists, pharmacological agents or xenobiotics that drive an adaptive 
response? Br J Pharmacol 174(11), 1209-1225. 
82. Kerimi A & Williamson G (2016) At the interface of antioxidant signalling and cellular 
function: Key polyphenol effects. Mol Nutr Food Res 60(8), 1770-1788. 
83. Monfoulet LE, Mercier S, Bayle D et al. (2017) Curcumin modulates endothelial 
permeability and monocyte transendothelial migration by affecting endothelial cell dynamics. 
Free Radic Biol Med 112, 109-120. 
84. Krga I, Tamaian R, Mercier S et al. (2018) Anthocyanins and their gut metabolites attenuate 
monocyte adhesion and transendothelial migration through nutrigenomic mechanisms regulating 
endothelial cell permeability. Free Radic Biol Med 124, 364-379. 
85. Alvarez-Cilleros D, Ramos S, Goya L et al. (2018) Colonic metabolites from flavanols 
stimulate nitric oxide production in human endothelial cells and protect against oxidative stress-
induced toxicity and endothelial dysfunction. Food Chem Toxicol 115, 88-97. 
86. Milenkovic D, Berghe WV, Morand C et al. (2018) A systems biology network analysis of 
nutri(epi)genomic changes in endothelial cells exposed to epicatechin metabolites. Sci Rep 8(1), 
15487. 
87. Rattan S (2014) Aging, health, hormesis and future lines of investigation. Aging Sci 2(3), 
1000e111. 
D
ow
nloaded from
 https://w
w
w
.cam
bridge.org/core . IN
RA
 - Versailles-G
rignon , on 06 N
ov 2019 at 15:09:33 , subject to the C
am
bridge C
ore term
s of use, available at https://w
w
w
.cam
bridge.org/core/term
s . https://doi.org/10.1017/S0007114519002733
Accepted manuscript 
29 
88. Son TG, Camandola S, Mattson MP (2008) Hormetic dietary phytochemicals. 
Neuromolecular Med 10(4), 236-246. 
89. Lewandowska U, Szewczyk K, Hrabec E et al. (2013) Overview of metabolism and 
bioavailability enhancement of polyphenols. J Agric Food Chem 61(50), 12183-12199. 
90. Yates AA, Erdman JW Jr, Shao A et al. (2017) Bioactive nutrients - Time for tolerable upper 
intake levels to address safety. Regul Toxicol Pharmacol 84, 94-101. 
91. Guo F, Moellering RD, Garvey WT (2014) The progression of cardiometabolic disease: 
validation of a new cardiometabolic disease staging system applicable to obesity. Obesity (Silver 
Spring) 22(1), 110-118. 
92. Bondonno CP, Yang X, Croft KD et al. (2012) Flavonoid-rich apples and nitrate-rich spinach 
augment nitric oxide status and improve endothelial function in healthy men and women: a 
randomized controlled trial. Free Radic Biol Med 52(1), 95-102. 
93. Hooper L, Kroon PA, Rimm EB et al. (2008) Flavonoids, flavonoid-rich foods, and 
cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin Nutr 88(1), 38-50. 
94. Medina-Remon A, Zamora-Ros R, Rotches-Ribalta M et al. (2011) Total polyphenol 
excretion and blood pressure in subjects at high cardiovascular risk. Nutr Metab Cardiovasc Dis 
21(5), 323-331. 
95. Sarria B, Mateos R, Sierra-Cinos JL et al. (2012) Hypotensive, hypoglycaemic and 
antioxidant effects of consuming a cocoa product in moderately hypercholesterolemic humans. 
Food Funct 3(8), 867-874. 
96. Haghighatdoost F & Hariri M (2019) Can resveratrol supplement change inflammatory 
mediators? A systematic review and meta-analysis on randomized clinical trials. Eur J Clin Nutr 
73(3), 345-355. 
97. Momose Y, Maeda-Yamamoto M, Nabetani H (2016) Systematic review of green tea 
epigallocatechin gallate in reducing low-density lipoprotein cholesterol levels of humans. Int J 
Food Sci Nutr 67(6), 606-613. 
D
ow
nloaded from
 https://w
w
w
.cam
bridge.org/core . IN
RA
 - Versailles-G
rignon , on 06 N
ov 2019 at 15:09:33 , subject to the C
am
bridge C
ore term
s of use, available at https://w
w
w
.cam
bridge.org/core/term
s . https://doi.org/10.1017/S0007114519002733
Accepted manuscript 
30 
98. Khan N, Monagas M, Andres-Lacueva C et al. (2012) Regular consumption of cocoa powder 
with milk increases HDL cholesterol and reduces oxidized LDL levels in subjects at high-risk of 
cardiovascular disease. Nutr Metab Cardiovasc Dis 22(12), 1046-1053. 
99. Sarria B, Martinez-Lopez S, Sierra-Cinos JL et al. (2015) Effects of bioactive constituents in 
functional cocoa products on cardiovascular health in humans. Food Chem 174, 214-218. 
100. Martinez-Lopez S, Sarria B, Sierra-Cinos JL et al. (2014) Realistic intake of a flavanol-rich 
soluble cocoa product increases HDL-cholesterol without inducing anthropometric changes in 
healthy and moderately hypercholesterolemic subjects. Food Funct 5(2), 364-374. 
101. Covas MI, Nyyssonen K, Poulsen HE et al. (2006) The effect of polyphenols in olive oil on 
heart disease risk factors: a randomized trial. Ann Intern Med 145(5), 333-341. 
102. Annuzzi G, Bozzetto L, Costabile G et al. (2014) Diets naturally rich in polyphenols 
improve fasting and postprandial dyslipidemia and reduce oxidative stress: a randomized 
controlled trial. Am J Clin Nutr 99(3), 463-471. 
103. Paquette M, Medina Larque AS, Weisnagel SJ et al. (2017) Strawberry and cranberry 
polyphenols improve insulin sensitivity in insulin-resistant, non-diabetic adults: a parallel, 
double-blind, controlled and randomised clinical trial. Br J Nutr 117(4), 519-531. 
104. Bozzetto L, Annuzzi G, Pacini G et al. (2015) Polyphenol-rich diets improve glucose 
metabolism in people at high cardiometabolic risk: a controlled randomised intervention trial. 
Diabetologia 58(7), 1551-1560. 
105. Grassi D, Lippi C, Necozione S et al. (2005) Short-term administration of dark chocolate is 
followed by a significant increase in insulin sensitivity and a decrease in blood pressure in 
healthy persons. Am J Clin Nutr 81(3), 611-614. 
106. Dower JI, Geleijnse JM, Gijsbers L et al. (2015) Effects of the pure flavonoids epicatechin 
and quercetin on vascular function and cardiometabolic health: a randomized, double-blind, 
placebo-controlled, crossover trial. Am J Clin Nutr 101(5), 914-921. 
107. Martin MA, Goya L, Ramos S (2017) Protective effects of tea, red wine and cocoa in 
diabetes. Evidences from human studies. Food Chem Toxicol 109(Pt 1), 302-314. 
D
ow
nloaded from
 https://w
w
w
.cam
bridge.org/core . IN
RA
 - Versailles-G
rignon , on 06 N
ov 2019 at 15:09:33 , subject to the C
am
bridge C
ore term
s of use, available at https://w
w
w
.cam
bridge.org/core/term
s . https://doi.org/10.1017/S0007114519002733
Accepted manuscript 
31 
108. Wedick NM, Pan A, Cassidy A et al. (2012) Dietary flavonoid intakes and risk of type 2 
diabetes in US men and women. Am J Clin Nutr 95(4), 925-933. 
109. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) (2010) Scientific Opinion 
on the substantiation of health claims related to cocoa flavanols and protection of lipids from 
oxidative damage (ID 652, 1372, 1506, 3143), and maintenance of normal blood pressure (ID 
1507) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal 8(10), 1792. 
110. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) (2012) Scientific Opinion 
on the substantiation of a health claim related to cocoa flavanols and maintenance of normal 
endothelium-dependent vasodilation pursuant to Article 13(5) of Regulation (EC) No 1924/2006. 
EFSA Journal 10(7), 2809. 
111. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) (2011) Scientific Opinion 
on the substantiation of health claims related to polyphenols in olive and protection of LDL 
particles from oxidative damage (ID 1333, 1638, 1639, 1696, 2865), maintenance of normal 
blood HDL-cholesterol concentrations (ID 1639), maintenance of normal blood pressure (ID 
3781), “anti-inflammatory properties” (ID 1882), “contributes to the upper respiratory tract 
health” (ID 3468), “can help to maintain a normal function of gastrointestinal tract” (3779), and 
“contributes to body defences against external agents” (ID 3467) pursuant to Article 13(1) of 
Regulation (EC) No 1924/2006. EFSA Journal 9(4), 2033. 
112. Woerdeman J, Del Rio D, Calani L et al. (2018) Red wine polyphenols do not improve 
obesity-associated insulin resistance: A randomized controlled trial. Diabetes Obes Metab 20(1), 
206-210. 
113. Auclair S, Chironi G, Milenkovic D et al. (2010) The regular consumption of a polyphenol-
rich apple does not influence endothelial function: a randomised double-blind trial in 
hypercholesterolemic adults. Eur J Clin Nutr 64(10), 1158-1165. 
114. Manach C, Milenkovic D, Van de Wiele T et al. (2017) Addressing the inter-individual 
variation in response to consumption of plant food bioactives: Towards a better understanding of 
their role in healthy aging and cardiometabolic risk reduction. Mol Nutr Food Res 61(6). 
D
ow
nloaded from
 https://w
w
w
.cam
bridge.org/core . IN
RA
 - Versailles-G
rignon , on 06 N
ov 2019 at 15:09:33 , subject to the C
am
bridge C
ore term
s of use, available at https://w
w
w
.cam
bridge.org/core/term
s . https://doi.org/10.1017/S0007114519002733
Accepted manuscript 
32 
115. Milenkovic D, Morand C, Cassidy A et al. (2017) Interindividual variability in biomarkers 
of cardiometabolic health after consumption of major plant-food bioactive compounds and the 
determinants involved. Adv Nutr 8(4), 558-570. 
116. Menezes R, Rodriguez-Mateos A, Kaltsatou A et al. (2017) Impact of flavonols on 
cardiometabolic biomarkers: a meta-analysis of randomized controlled human trials to explore 
the role of inter-individual variability. Nutrients 9(2), pii: E117. 
117. Gonzalez-Sarrias A, Combet E, Pinto P et al. (2017) A systematic review and meta-analysis 
of the effects of flavanol-containing tea, cocoa and apple products on body composition and 
blood lipids: exploring the factors responsible for variability in their efficacy. Nutrients 9(7), 
746. 
118. Garcia-Conesa MT, Chambers K, Combet E et al. (2018) Meta-analysis of the effects of 
foods and derived products containing ellagitannins and anthocyanins on cardiometabolic 
biomarkers: analysis of factors influencing variability of the individual responses. Int J Mol Sci 
19(3), pii: E694. 
119. Martini D, Chiavaroli L, Gonzalez-Sarrias A et al. (2019) Impact of foods and dietary 
supplements containing hydroxycinnamic acids on cardiometabolic biomarkers: a systematic 
review to explore inter-individual variability. Nutrients 11(8), pii: E1805. 
D
ow
nloaded from
 https://w
w
w
.cam
bridge.org/core . IN
RA
 - Versailles-G
rignon , on 06 N
ov 2019 at 15:09:33 , subject to the C
am
bridge C
ore term
s of use, available at https://w
w
w
.cam
bridge.org/core/term
s . https://doi.org/10.1017/S0007114519002733
Accepted manuscript 
33 
Table 1. Overview of the protective effects of polyphenols on cardiometabolic health - evidence from human studies. 1 
Study design Polyphenol, and dose Duration Participants 
(N, and health status) 
Cardiometabolic outcomes Reference 
Observational 
study of the 
subcohort of the 
Polish arm of the 
HAPIEE cohort 
Dietary data were collected by 
using a food frequency 
questionnaire consisted of 148 
food and drink items. 
The polyphenol content in 
foods were obtained from the 
Phenol-Explorer database. 
4 years 5806 adults aged 45-69 years 
recruited in the urban area of 
Krakow, Poland. 
Healthy volunteers free of 
diabetes. 
When comparing extreme quartiles, intake 
of total polyphenol was inversely associated 
with the risk of type 2 diabetes. 
(4) 
Observational 
study of the 
subcohort of the 
PREDIMED trial 
Two Mediterranean diets: 
-extra-virgin olive oil 
(1L/week for all the family) 
or 
-extra-virgin olive oil plus 
mixed nuts (30 g/day, as 15 g 
walnuts, 7.5 g almonds and 
7.5 g hazelnuts). 
1 year of 
intervention 
1139 older volunteers at high 
risk of cardiovascular disease 
within the PREDIMED trial. 
Participants in the highest tertile of changes 
in total urinary polyphenol excretion 
showed: 
-decrease in plasma levels of inflammatory 
biomarkers (vascular cell adhesion 
molecule 1, intercellular adhesion molecule 
1, interleukin 6, tumor necrosis factor alpha, 
monocyte chemotactic protein 1), 
-decrease in systolic and diastolic blood 
pressure and 
-increase in plasma high-density lipoprotein 
cholesterol. 
(5) 
Controlled 
randomized 
clinical study 
300 mg of green tea 
polyphenol extract 
(Polyphenon E) twice a day. 
1 week Twenty-two male volunteers 
(12 smokers and 10 non-
smokers) aged between 22 and 
32 years. 
Increased resistance of LDL to oxidation. (11) 
Randomized, 
cross-over 
controlled trial 
25 mL/d raw high-polyphenol-
content olive oil (HPCOO; 
366 mg/kg) or low-
polyphenol-content olive oil 
(LPCOO; 2.7 mg/kg). 
3 weeks 25 healthy European men, 
aged 20-59 years. 
-Plasma apoB-100 concentrations and the 
number of total and small LDL particles 
decreased after the HPCOO intervention, 
which increased with LPCOO intervention. 
-LDL oxidation lag time increased with 
HPCOO intervention. 
-Lipoprotein lipase gene expression tended 
to increase after the HPCOO intervention 
and did not change after the LPCOO 
intervention. 
(12) 
Longitudinal 
investigation 
study 
Mean estimated flavonoid 
intake was 26 mg/day. 
5 years 805 men aged 65-84 years. Flavonoid intake was significantly inversely 
associated with mortality from coronary 
heart disease and showed an inverse relation 
(59) 
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with incidence of myocardial infarction. 
Double-blind, 
crossover, dose-
response, 
randomized, 
placebo-
controlled trial 
Pomegranate extract. 
Dose 1: 160 mg phenolics/day 
or 
Dose 2: 640 mg phenolics/day. 
3 weeks Forty-nine participants (body 
mass index > 27 kg/m2). 
After Dose 2, total cholesterol, LDL- 
cholesterol, small LDL-cholesterol, non-
HDL-cholesterol, apolipoprotein-B and 
oxidized LDL-cholesterol decreased, but 
only in urolithin metabotype B subjects. 
(76) 
Double-blind, 
placebo- 
controlled 
crossover study 
Soy isoflavones (80 mg 
aglycone equivalents). 
Acute study Male equol producers and 
non-equol producers; 
14 per group, at moderate 
cardiovascular risk. 
Arterial stiffens (carotid-femoral pulse-
wave velocity) significantly improved in 
equol producers at 24 h, which was 
significantly associated with plasma equol 
concentrations. 
(77) 
Randomized 
controlled 
crossover (Latin-
square) designed 
study 
120 g of apple flesh and 80 g 
of apple skins that provided 
184 mg of quercetin and 180 
mg of (-)-epicatechin. 
Acute study Healthy men and women, 
N=30. 
Increased flow-mediated dilatation. 
Decreased pulse pressure and systolic blood 
pressure. 
(92) 
Cross-sectional 
substudy of the 
PREDIMED trial 
Intake of fruit, vegetables, 
coffee, wine. 
5-year follow up 
study 
589 volunteers (men and 
women) free of cardiovascular 
disease at baseline and 
fulfilled at least one of the 
following two criteria: (1) type 
2 diabetes mellitus and/ or (2) 
three or more coronary heart 
disease risk factors. 
An inverse association was observed 
between urinary total polyphenol excretion 
(TPE) and the prevalence of hypertension. 
Participants in the highest quartile of 
urinary TPE had a reduced prevalence of 
hypertension compared to those in the 
lowest quartile. 
Systolic and diastolic blood pressure were 
inversely associated with urinary TPE after 
adjustment for potential confounders. 
(94) 
Non-controlled, 
non-randomized, 
open intervention 
trial 
Two servings per day cocoa 
product which provided 12 g 
of dietary fiber and 283 mg of 
soluble polyphenols. 
2 months 21 volunteers (women and 
men), moderately 
hypercholesterolemic, non-
vegetarian, non-smoker, 
between 18 and 45 years old, 
with a body mass index under 
30 kg/m2, not suffering from 
any other chronic pathology. 
Glucose, systolic and diastolic blood 
pressure, and malondialdehyde decreased, 
while HDL-cholesterol slightly increased. 
(95) 
Randomized, 
crossover and 
controlled clinical 
trial 
500 mL of skimmed milk/day 
with or without 40 g of cocoa 
powder that provided 495.2 
mg of total polyphenols and 
425.7 mg of 
4 weeks Forty-two high-risk volunteers 
(19 men and 23 women), 
mean age 69.7 years. 
Increased HDL-cholesterol. 
Decreased oxidized LDL. 
(98) 
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proanthocyanidins. 
Controlled, cross-
over studies in 
free-living 
condition 
Soluble cocoa product rich in 
dietary fibre (DFCP) 
providing daily 10.17 g, 43.8 
mg and 168.6 mg of total-
dietary-fibre, flavanols and 
methylxanthines, respectively 
and a product rich in 
polyphenols (PPCP) providing 
daily 3.74 g, 45.3 mg and 
109.8 mg of total-dietary-
fibre, flavanols and 
methylxanthines, respectively. 
4 weeks N=44, men and women, 
between 18 and 55 years old, 
normocholesterolemic and 
moderately 
hypercholesterolemic subjects, 
non-vegetarian, non-smoker, 
not suffering from any chronic 
pathology or gastrointestinal 
disorder, body mass index was 
under 30 kg/m2. 
Both products increased HDL-cholesterol 
concentrations, whereas only DFCP 
decreased glucose and IL-1β levels in all 
subjects. 
(99) 
Non-randomized, 
controlled, 
crossover study of 
free-living 
individuals 
Soluble cocoa product 
providing 45.3 mg of flavanols 
per day, in milk. 
4 weeks Normocholesterolemic (N=24; 
25.9 ± 5.6 years) 
and 
moderately 
hypercholesterolemic (N=20; 
30.0 ± 10.3 years) volunteers. 
Increase in HDL-cholesterol. 
Decrease in IL-10. 
(100) 
Randomized, 
crossover, 
controlled trial 
25 mL of 3 olive oils. 
Olive oils had low (2.7 mg/kg 
of olive oil), medium (164 
mg/kg), or high (366 mg/kg) 
phenolic content but were 
otherwise similar. 
3 weeks 200 healthy male volunteers. A linear increase in HDL-cholesterol levels 
was observed for low-, medium-, and high-
polyphenol olive oil. 
Total cholesterol/HDL-cholesterol ratio 
decreased linearly with the phenolic content 
of the olive oil. 
Oxidative stress markers decreased linearly 
with increasing phenolic content. 
(101) 
Randomized 
controlled study 
Diet rich in polyphenols. 8 weeks Eighty-six individuals of both 
sexes, aged 35-70 years, with 
a large body mass index (27-
35 kg/m2) and large waist 
circumference (men, >102 cm; 
women, >88 cm) and any 
other component of the 
metabolic syndrome. 
Decrease of fasting plasma triglyceride 
concentrations. 
Decrease of postprandial plasma 
triglyceride total area under curve. 
Decrease of urinary 8-isoprostane. 
(102) 
Parallel, double-
blind, controlled 
and randomized 
clinical trial 
Strawberry and cranberry 
polyphenols, 333 mg/day. 
6 weeks Free-living insulin-resistant 
overweight or obese human 
subjects (N=41). 
Increased insulin sensitivity. (103) 
Downloaded from https://www.cambridge.org/core. INRA - Versailles-Grignon, on 06 Nov 2019 at 15:09:33, subject to the Cambridge Core terms of use, available at https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0007114519002733
Accepted manuscript 
36 
Randomized 
controlled study 
Diet rich in polyphenols. 8 weeks Eighty-six individuals of both 
sexes, aged 35-70 years, with 
overweight or obesity (body 
mass index 27-35 kg/m2) and 
large waist circumference 
(men, >102 cm; women, >88 
cm) and at least one more 
component of the metabolic 
syndrome. 
During OGTT, polyphenols significantly 
reduced plasma glucose total area under 
curve and increased early insulin secretion. 
Improved post-challenge oral glucose 
insulin sensitivity. 
(104) 
Randomized, 
crossover, 
controlled trial 
100 g dark chocolate bars 
containing ≈500 mg 
polyphenols. 
15 days 15 healthy persons (7 men and 
8 women) aged 33.9 ± 7.6 
years. 
Improved insulin sensitivity. 
Decreased systolic blood pressure. 
(105) 
Randomized, 
double-blind, 
placebo-
controlled, 
crossover trial 
(-)-epicatechin, 100 mg/day. 4 weeks Thirty-seven apparently 
healthy men and women aged 
40-80 years with a systolic 
blood pressure between 125 
and 160 mm Hg at screening. 
Reduced insulin resistance. (106) 
Prospective 
cohort studies 
Flavonoid intakes were 
assessed using food frequency 
questionnaires. 
For quantification of the 
flavonoid content in various 
food sources, a comprehensive 
database of levels of 
individual flavonoids in foods 
was established predominantly 
on the basis of the USDA 
flavonoid content of the foods 
database. 
1984-2008 
1991-2007 
1986-2006 
70359 women in the Nurses’ 
Health Study (NHS; 1984-
2008), 
89201 women in the NHS II 
(1991-2007), and 
41334 men in the Health 
Professionals Follow-Up 
Study (1986-2006) 
who were free of diabetes, 
cardiovascular disease, and 
cancer at baseline. 
Higher intakes of anthocyanins were 
significantly associated with a lower risk of 
type 2 diabetes, after multivariate 
adjustment for age, body mass index, and 
lifestyle and dietary factors. 
(108) 
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